LivingGLP1
Study S001661

Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov record

Registration

Registration
NCT05779644
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
UNKNOWN
Enrollment
300
Start
2023-02-23
Primary completion
2025-02-23
Lead sponsor
RenJi Hospital
Conditions
Metformin; Obesity, Abdominal; Diabetes Mellitus, Type 2; Abdominal Fat; Non-Alcoholic Fatty Liver Disease; Metabolism Disorder, Glucose; Metabolism Disorder, Lipid
Interventions
DRUG:Liraglutide; DRUG:Semaglutide; DRUG:Metformin
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Blood glucose [The twelfth week of treatment]
  • Blood insulin [The twelfth week of treatment]
  • Total cholesterol [The twelfth week of treatment]
  • Triglyceride [The twelfth week of treatment]
  • Lipoprotein [The twelfth week of treatment]
  • Weight [The twelfth week of treatment]
  • Abdominal fat distribution [The twelfth week of treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.